BioXcel Therapeutics, Inc. Operating Cash Flow
BioXcel Therapeutics, Inc. (BTAI) reported Operating Cash Flow of -$17.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.10M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.81M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$14.21M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$18.79M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$57.62M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$72.03M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$155.01M.
- BioXcel Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$135.34M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$17.91M 10-Q · filed 2026-08-13 | -$32.12M derived: sum of 3 quarters · filed 2026-08-13 | -$50.90M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$11.81M 10-Q · filed 2026-05-15 | -$26.02M derived: sum of 2 quarters · filed 2026-05-15 | -$44.81M derived: sum of 3 quarters · filed 2026-05-15 | -$57.38M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$14.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$33.00M derived: sum of 2 quarters · filed 2026-03-27 | -$45.57M derived: sum of 3 quarters · filed 2026-08-13 | -$57.62M 10-K · filed 2026-03-27 | ||
| 2025-09-30 | -$18.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$31.36M derived: sum of 2 quarters · filed 2026-08-13 | -$43.41M 10-Q · filed 2025-11-12 | -$58.21M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$12.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$24.62M 10-Q · filed 2026-08-13 | -$39.43M derived: sum of 3 quarters · filed 2026-08-13 | -$55.77M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$12.04M 10-Q · filed 2026-05-15 | -$26.85M derived: sum of 2 quarters · filed 2026-05-15 | -$43.19M derived: sum of 3 quarters · filed 2026-05-15 | -$66.36M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$31.15M derived: sum of 2 quarters · filed 2026-03-27 | -$54.32M derived: sum of 3 quarters · filed 2026-03-27 | -$72.03M 10-K · filed 2026-03-27 | ||
| 2024-09-30 | -$16.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$39.51M derived: sum of 2 quarters · filed 2025-11-12 | -$57.22M 10-Q · filed 2025-11-12 | -$84.08M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$23.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$40.88M 10-Q · filed 2025-08-12 | -$67.74M derived: sum of 3 quarters · filed 2025-08-12 | -$105.33M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$17.71M 10-Q · filed 2025-05-12 | -$44.57M derived: sum of 2 quarters · filed 2025-05-12 | -$82.15M derived: sum of 3 quarters · filed 2025-05-12 | -$120.36M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | -$26.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$64.45M derived: sum of 2 quarters · filed 2025-03-28 | -$102.65M derived: sum of 3 quarters · filed 2025-03-28 | -$155.01M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$37.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$75.79M derived: sum of 2 quarters · filed 2024-11-14 | -$128.14M 10-Q · filed 2024-11-14 | -$166.78M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$38.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$90.56M 10-Q · filed 2024-08-06 | -$129.20M derived: sum of 3 quarters · filed 2024-08-06 | -$160.38M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$52.35M 10-Q · filed 2024-05-09 | -$90.99M derived: sum of 2 quarters · filed 2024-05-09 | -$122.18M derived: sum of 3 quarters · filed 2024-05-09 | -$155.28M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$38.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$69.83M derived: sum of 2 quarters · filed 2024-03-22 | -$102.93M derived: sum of 3 quarters · filed 2024-03-22 | -$135.34M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | -$31.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$64.29M derived: sum of 2 quarters · filed 2023-11-14 | -$96.70M 10-Q · filed 2023-11-14 | -$116.63M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$33.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$65.52M 10-Q · filed 2023-08-14 | -$85.45M derived: sum of 3 quarters · filed 2023-08-14 | -$105.65M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$32.41M 10-Q · filed 2023-05-09 | -$52.34M derived: sum of 2 quarters · filed 2023-05-09 | -$72.54M derived: sum of 3 quarters · filed 2023-05-09 | -$94.93M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$19.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$40.13M derived: sum of 2 quarters · filed 2023-03-16 | -$62.51M derived: sum of 3 quarters · filed 2023-03-16 | -$82.15M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$42.58M derived: sum of 2 quarters · filed 2022-11-14 | -$62.22M 10-Q · filed 2022-11-14 | -$82.49M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$22.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$42.02M 10-Q · filed 2022-08-11 | -$62.29M derived: sum of 3 quarters · filed 2022-08-11 | -$81.39M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$19.64M 10-Q · filed 2022-05-09 | -$39.91M derived: sum of 2 quarters · filed 2022-05-09 | -$59.01M derived: sum of 3 quarters · filed 2022-05-09 | -$73.83M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$20.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$39.37M derived: sum of 2 quarters · filed 2022-03-11 | -$54.19M derived: sum of 3 quarters · filed 2022-03-11 | -$66.35M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | -$19.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$33.92M derived: sum of 2 quarters · filed 2021-11-10 | -$46.08M 10-Q · filed 2021-11-10 | -$54.00M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$14.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$26.98M 10-Q · filed 2021-08-10 | -$34.90M derived: sum of 3 quarters · filed 2021-08-10 | -$42.38M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | -$12.16M 10-Q · filed 2021-05-10 | -$20.08M derived: sum of 2 quarters · filed 2021-05-10 | -$27.56M derived: sum of 3 quarters · filed 2021-05-10 | -$33.59M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$7.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$15.40M derived: sum of 2 quarters · filed 2021-03-12 | -$21.43M derived: sum of 3 quarters · filed 2021-03-12 | -$27.10M 10-K · filed 2021-03-12 | -$27.28M 10-K · filed 2020-03-09 | |
| 2019-09-30 | -$7.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$13.51M derived: sum of 2 quarters · filed 2020-11-12 | -$19.18M 10-Q · filed 2020-11-12 | -$19.36M 10-Q · filed 2019-11-14 | -$23.52M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$6.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$11.70M 10-Q · filed 2020-08-14 | -$16.04M derived: sum of 3 quarters · filed 2020-08-14 | -$19.22M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | -$5.67M 10-Q · filed 2020-05-12 | -$10.01M derived: sum of 2 quarters · filed 2020-05-12 | -$13.20M derived: sum of 3 quarters · filed 2020-05-12 | -$18.17M derived: sum of 4 quarters · filed 2020-05-12 | ||
| 2018-12-31 | -$4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$7.53M derived: sum of 2 quarters · filed 2020-03-09 | -$12.50M derived: sum of 3 quarters · filed 2020-03-09 | -$13.51M 10-K · filed 2020-03-09 | ||
| 2018-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$8.16M derived: sum of 2 quarters · filed 2019-11-14 | -$9.17M 10-Q · filed 2019-11-14 | -$10.27M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$5.98M 10-Q · filed 2019-08-06 | -$7.08M derived: sum of 3 quarters · filed 2019-08-06 | -$7.40M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | -$1.01M 10-Q · filed 2019-05-07 | -$2.11M derived: sum of 2 quarters · filed 2019-05-07 | -$2.43M derived: sum of 3 quarters · filed 2019-05-07 | -$2.78M derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2017-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$1.42M derived: sum of 2 quarters · filed 2019-03-12 | -$1.76M derived: sum of 3 quarters · filed 2019-03-12 | -$2.20M 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$322.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$667.00K derived: sum of 2 quarters · filed 2018-11-09 | -$1.10M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$776.00K 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | -$431.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |